Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Interim Management Statement

2 Feb 2010 07:00

RNS Number : 4992G
e2v technologies PLC
02 February 2010
Β 

ο»Ώ

2 February 2010

Β 

e2v technologies plc

Β 

Interim Management Statement

Β 

e2v technologies, the specialist developer and manufacturerΒ of high technology components and sub-systems, is today providing this Interim Management Statement coveringΒ the periodΒ from 1 October 2009 to 1 February 2010.

Β 

Group trading since the half year has continued in line with management's expectations and this reflects general market softness.

Β 

In the Electron Devices and Subsystems division, the science and medical sector for radiotherapy new equipment sales has stabilised with spares revenues steady, while commercial and industrial markets show some signs of recovery. The defence sector has performed below expectations, reflecting lower levels of new order placement which we anticipate will continue into the next financial year.

Β 

Within Imaging, performance reflects the continued lower demand in the dental markets, partially offset by increased activity in space related applications. The commercial and industrial sector is stable but with some signs of recovery.

Β 

Specialist Semiconductors has grown with QP Semiconductors offsetting the decline in the underlying business. Demand in the defence sector remains firm.

Β 

Sensors, the smallest division, has continued to achieve modest growth across its portfolio of businesses.

Β 

Order intake in the quarter was equivalent to sales, resulting in a closing order book for use over the coming 12 months of Β£105m (31 December 2008: Β£108m at constant exchange rates).

Β 

The formal employee consultations in relation to the potential restructuring in France and the UK are in line with our planned timetable. The scale of the programme has led to some level of disruption and this risk remains. The overall restructuring programme continues to be subject to close management attention.

Β 

Net borrowings* at 31 December 2009 decreased from the 30 September 2009 by Β£52.8m to Β£52.4m. This was primarily due to the firm placing and rights issue announced on 29 October 2009, the gross proceeds of which were Β£55.8m.

Β 

*Note: Net borrowings excludes capitalised borrowing costs

Β 

Β 

Β 

Β 

For further information:

Β 

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Charles Hindson

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7831 3113

Jon Simmons/Sophie Kernon

Β 

NOTES FOR EDITORS

Β 

e2v

Β 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets.

Β 

e2v is organised into four divisions:

Β 

Β·; High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, radar systems, industrial heating, satellite communications amplifiers and digital television transmitters.

Β·; Advanced CCD and CMOS imaging sensors and cameras for applications including space, science and life science imaging, industrial process control, intra-oral and panoramic dental X-ray systems, military surveillance and automotive imaging.

Β·; Specialist SemiconductorsΒ -Β including logic, memory and microprocessors forΒ high reliability microprocessor and MRAM requirements, in partnership with Freescale SemiconductorΒ andΒ Everspin,Β mission-critical avionics and defence programs requiring high reliability integrated circuits, high speed data convertersΒ and sensor data acquisitionΒ utilising mixed signal application specific devices.

Β·; A range of professional sensing products for applications including environmental safety, x-ray spectroscopy, automotive alarm and security systems, microwave radar and safety and arming devices, fire rescue and security thermal imaging.

Β 

For the year ended 31 March 2009, e2v achieved sales of Β£233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base.

Β 

The Company is headquartered in the United Kingdom and has approximately 1500 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Β 

Further information is available from www.e2v.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSUGUQPPUPUGBG
Date   Source Headline
29th Nov 20123:17 pmRNSHolding(s) in Company
23rd Nov 201211:15 amRNSHolding(s) in Company
23rd Nov 201211:15 amRNSHolding(s) in Company
20th Nov 20124:45 pmRNSNotification of Major Interest in Shares
20th Nov 201210:40 amRNSHolding(s) in Company
19th Nov 20129:00 amRNSHolding(s) in Company
15th Nov 201210:25 amRNSTotal Voting Rights
12th Nov 20124:40 pmRNSSecond Price Monitoring Extn
12th Nov 20124:35 pmRNSPrice Monitoring Extension
12th Nov 20123:21 pmRNSHolding(s) in Company
12th Nov 201211:30 amRNSHolding(s) in Company
5th Nov 20127:00 amRNSHalf-year results for six months to 30 September
1st Nov 20123:59 pmRNSDirector/PDMR Shareholding
11th Oct 20127:00 amRNSPeriod End Update
2nd Oct 20122:30 pmRNSHolding(s) in Company
26th Sep 20125:00 pmRNSAdditional Listing Announcement - Amendment
25th Sep 201210:00 amRNSTotal Voting Rights
21st Sep 20124:49 pmRNSAdditional Listings Announcement
13th Sep 20124:49 pmRNSShare Buy-back Programme Update
25th Jul 201212:12 pmRNSAGM - notification of proxy votes
25th Jul 20127:00 amRNSInterim Management Statement
10th Jul 201212:30 pmRNSTotal Voting Rights
3rd Jul 20124:30 pmRNSAwards under Long Term Incentive Plan
29th Jun 201210:21 amRNSAwards under Deferred Bonus Plan
18th Jun 201211:15 amRNSTotal Voting Rights
24th May 20123:30 pmRNSBlock Listing Return
22nd May 20123:15 pmRNSDirector/PDMR Shareholding
22nd May 20123:15 pmRNSTotal Voting Rights
21st May 20129:42 amRNSFinal Dividend Timetable
21st May 20127:00 amRNSResults for the year ended 31 March 2012
16th May 20127:00 amRNSSale of non-core businesses
15th May 201210:30 amRNSTotal Voting Rights
19th Apr 20127:00 amRNSYear end trading update
1st Mar 201211:20 amRNSTotal Voting Rights
27th Feb 20122:36 pmRNSHolding(s) in Company
27th Feb 201212:39 pmRNSHolding(s) in Company
20th Feb 20127:00 amRNSMemorandum of Understanding with Rio Tinto
1st Feb 201210:45 amRNSTotal Voting Rights
30th Jan 20127:00 amRNSInterim Management Statement
5th Jan 20123:41 pmRNSTotal Voting Rights
22nd Dec 201110:56 amRNSTotal Voting Rights
19th Dec 20117:16 amRNSShare Buyback
1st Dec 20113:56 pmRNSTotal Voting Rights
18th Nov 201112:44 pmRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSHalf Yearly Report
13th Oct 20117:00 amRNSPeriod end update
6th Oct 20115:57 pmRNSAnnouncement Released In Error
6th Oct 20115:20 pmRNSHolding(s) in Company
6th Oct 20115:15 pmRNSHolding(s) in Company
3rd Oct 201112:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.